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group compared to Sham group. Intestinal microvilli were
lost, disrupted and the interspace between cells became
wider in Model group. Pretreatment with Biﬁdobacterium
ZYB0401 or Lactobacillus ZYL0401 increased the counts
of Biﬁdobacterium and Lactobacillus in ileal, markedly
ameliorated intestinal mucosal structure and also decreased
plasma endotoxin, serum TNF-a (p < 0.05).
Conclusion: Pretreatment with Biﬁdobacterium ZYB0401
or Lactobacillus ZYL0401 could improve intestinal mucous
barrier, reduced plasma edotoxin and serum TNF-a levels.
Project supported by the National Basic Research Program
(973) of China (No. 2003CB515506), Postdoctoral Fund of
China (20040350233) and Postdoctoral Fund of Zhejiang
Province.
OL-024 A clinical study on metabolic syndrome in
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W.Y. Zhang*, X.L. Fan. Beijing Ditan Hospital, Beijing
100011, China
Objective: To explore the incidence of metabolic syndrome
(MS) and its clinical characteristics in patients with HCV-
related liver cirrhosis (LCC) from Beijing.
Methods: The incidence of various metabolic disorders in
104 patients with LCC was studied by checking serum
biochemistry, body mass index (BMI), virus load, colored
ultra sonic and etc. According to their metabolic disorders,
two groups were established: LCC with metabolic syndrome
group (LCC+MS) and LCC without metabolic syndrome group
(LCC-MS).The incidence of metabolic disorders in LCC+MS
patients was compared with that in LCC-MS patients.
Results: The incidence of hyperglycemia, hypertension,
obesity, hypertriglyceridemia, hypercholesteremia and MS
in the LCC patients was 70%, 27%, 25%, 15.96%, 6% and
26.92% respectively. BMI, blood pressure and triglyceride in
LCC+MS patients were signiﬁcantly higher than those in LCC-
MS patients. There was no signiﬁcant difference for blood
glucose, cholesterol and ALT between LCC-MS patients and
LCC+MS patients. Unconditional Logistic regression analysis
revealed that BMI was the independent risk factor affecting
the incidence of MS in LCC patients.
Conclusions: Patients with LCC had higher incidence of
hyperglycemia and obesity. Hypertension, obesity and the
abnormality of triglyceride metabolism probably played
important roles in HCV-related cirrhosis with metabolic
syndrome. BMI was an important factor affecting the
complication of MS in LCC patients.
OL-025 Inﬂuence of pregnancy on the development of
liver cancer in rats
Z.Y. Shao*, J. Xin, X. Zhou, G.D. Xia, K. Wang, F. Li. China
Hepatic cancer predominantly occurs in Males. This is almost
a commonsense to most of us. But the detailed mechanisms
underlying such phenomenon are still not well-known. The
average age of liver cancer patients are about 30 40 years
old. So most female patients have udergone pregnancy at
least one time. Pregnancy is a very important event before
or during the development of liver cancer in females. In this
special period, not only sex hormones secrete in a strange
manner, but also immune system functions in a special
module which is very different from normal. So it is urgent
to investigate the impact of process of pregancy on the
development of hepatic cancer. In this study, 100 female
SD rats are randomly divided into two groups: pregance
group and control group. Rats in both groups are injected IV
Diethylnitrosomine (a chemical carcinogen). In pregnance
group, rats are raised together with male rats in 3:1 ratio
(3 female, 1 male) to make every rats undergo pregnancy.
While in control group, rats are coupled with spermaduct-
ligated male rats. The size and amount of hepatic cancers in
pregnancy group are smaller and less than those in control
group. The survial rate is also signiﬁcantly higer than that in
control group. We conclude that the process of pregnancy
exerts an inhibitory role in the development of chemical
induced hepatic cancer in rats.
Acknowledgement: This project was sponsored by the
National Natural Science Foundation of China. The number
of the grant is 30600727.
OL-026 Expression of TGFb1, TIMP1 in liver cirrhosis
and pathological signiﬁcance
Y. Jiang*. Department of infectious, the Second Afﬁliated
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China
Objective: To detect the expression of transforming growth
factor beta 1 (TGFb1), tissue inhibitors of tissue inhibitors
of metalloproteinase-1 (TIMP1) in liver cirrhosis tissues.
Methods: All 52 liver cirrhosis specimens were detected by
immunohistochemistry (S-P).
Results: Proteins of TGFb1 and TIMP1 were detected in all
liver tissues from 52 liver cirrhosis patients, all in cytoplasm
but not nucleus.
Conclusion: TGFb1and TIMP1 may play an important role
in the development of liver cirrhosis, especially they were
tightly correlated with clinical pathologic factors.
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Objective: To investigate the dynamic expression of Rho-
Kinase-I (ROCK-I), p-myosin-binding subunit (MBS) Thr-697,
alpha smooth muscle actin (a-SMA) and their mRNA, the
changes of actin cytoskeleton in liver tissues during hepatic
ﬁbrogenesis.
Methods: The Sprague Dawley rats were randomly divided
into two groups, i.e., sham operation group and model group
(bile duct ligation to induce hepatic ﬁbrogenesis). Livers
were harvested at 1wk, 2wk, 3wk and 4wk after operation
respectively in model group and 4wk after operation in
sham group. Histopathological changes were evaluated by
hematoxylin and eosin staining and by Masson’s trichrome
method. Proteins of ROCK-I, p-MBS Thr-697 in the livers were
detected by Western blot and their mRNA were measured
by reverse transcription-polymerase chain reaction (RT-
PCR), while the distribution of ROCK-I, a-SMA in the livers
were assessed immunohistochemistry. The changes ofb-actin
cytoskeleton were studied by ﬂuorescence.
Results: With the development of hepatic ﬁbrosis, the
number of cells expressed ROCK-I and a-SMA in liver tissues
increased obviously in model group. They mainly resided in
the cells of portal vein, ﬁber septa, presinusoid and around
the proliferation bile ducts. The positive areas of ROCK-I
and a-SMA In rat livers from model groups at week 1 to
4 were 14.71%±4.01% and 13.62%±1.48%, 20.66%±2.34%
and 23.25%±2.02%, 26.21%±1.74% and 27.92%±1.61%,
32.50%±2.55% and 33.69%±1.99% respectively, which were
larger than those in control group (5.35%±1.30%, 6.22%
±1.56%) respectively, P < 0.05. aExpression of ROCK-I pro-
teins, p-MBS Thr-697 proteins and a-SMAproteins in rat livers
tissues in model groups was increased by 83%, 80% and 48%
at week 1, by 114%, 137% and 87% at week 2, by 196%, 229%
and 149% at week 3, by 233%, 334% and 210% at week 4re-
spectively, compared with that in control group. Both a-SMA
